Objective To determine the relationship between human fibroblast growth factor 21 (FGF21) and thyroid stimulating hormone (TSH) by testing the level of FGF21, lipid metabolism, and carbohydrate metabolism-related indices, as well as the level of TSH, among metabolic syndrome-free patients with normal physical examination results.
Methods An enzyme-linked immunosorbent assay (ELISA) was used to test the levels of serum FGF21 and free fatty acids (FFA) in metabolic syndrome-free patients with normal physical examination results, and electrochemiluminescence (ECLIA) was used to measure TSH, thyroglobulin antibodies (TGAbs), and thyroid peroxidase antibody (TPOAb) levels.
Results Three hundred fifty-six metabolic syndrome-free patients (116 males and 240 females; average age, 43±13 years) with normal physical examination results were enrolled. Among the patients with normal physical examination results, FGF21 had a weak relationship with obesity indices, such as the waist circumference (r=0.110, P=0.038), the waist-to-hip ratio (r=0.119, P=0.025), and the triglycerides level (TG; r=0.302, P=0.000), and a weak relationship with blood lipid levels, such as total cholesterol (TCHO; r=0.113, P=0.012) and low-density lipoprotein-cholesterol (LDL-C; r=0.175, P=0.001), but no relationship with TSH (r=–0.023, P=0.666). In addition, the FGF21 levels in thyroid autoantibody-positive and -negative groups were not significantly different.
Conclusion Among the metabolic syndrome-free patients with normal physical examination results, FGF21 has no apparent relationship with TSH or thyroid autoimmunity.
- Human fibroblast growth factor 21 (FGF21)
- Thyroid stimulating hormone (TSH)
- Free fatty acids (FFA)
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 Unported License (CC BY-NC 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.